Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion.
| Data(s) |
2015
|
|---|---|
| Identificador |
https://serval.unil.ch/?id=serval:BIB_DA645CAAB37A isbn:1533-4406 (Electronic) pmid:26332554 doi:10.1056/NEJMcibr1506573 isiid:000360439500017 |
| Idioma(s) |
en |
| Fonte |
New England Journal of Medicine, vol. 373, no. 10, pp. 974-976 |
| Palavras-Chave | #Benzhydryl Compounds/pharmacology; Diabetes Mellitus, Type 2/drug therapy; Diabetes Mellitus, Type 2/metabolism; Glucagon/secretion; Glucagon-Secreting Cells/metabolism; Glucose/metabolism; Glucosides/pharmacology; Humans; Sodium-Glucose Transporter 1/metabolism; Sodium-Glucose Transporter 2/antagonists & inhibitors; Sodium-Glucose Transporter 2/metabolism |
| Tipo |
info:eu-repo/semantics/article article |
